Core Viewpoint - Wanrun Co., Ltd. announced that its subsidiary, Jiummu Chemical, has received an acceptance notice from the Beijing Stock Exchange for its application to publicly issue shares to unspecified qualified investors and list on the exchange [1] Company Overview - Jiummu Chemical primarily engages in the research, development, production, and sales of OLED front-end materials, including OLED sublimation materials and intermediates [4] - Wanrun Co., Ltd. holds 85 million shares in Jiummu Chemical, accounting for 45.33% of the total share capital, making it the controlling shareholder [4] Financial Performance - Revenue for Jiummu Chemical during the reporting period (2022 to the first quarter of 2025) was 706 million yuan, 878 million yuan, 962 million yuan, and 208 million yuan respectively [5] - The net profit excluding non-recurring gains and losses for the same periods was 197 million yuan, 203 million yuan, 246 million yuan, and 46.5 million yuan [5] - The company's main revenue source, OLED sublimation materials and intermediates, accounted for 93.65%, 94.38%, 95.84%, and 95.47% of total revenue during the reporting periods [5] Sales and Market Dynamics - Jiummu Chemical's sales are primarily export-oriented, with overseas sales accounting for 82.15%, 88.51%, 92.69%, and 89.69% of total revenue [7] - The company relies heavily on a few key customers, with sales to the top five customers representing 72.93%, 71.40%, 77.45%, and 67.93% of total revenue [7] Risks and Challenges - The company faces potential risks from fluctuations in exchange rates, as its overseas sales are primarily priced in USD, which can impact revenue and foreign exchange gains or losses [8] - Jiummu Chemical reported negative foreign exchange gains of -11.5 million yuan, -6.94 million yuan, -13.98 million yuan, and -2.00 million yuan during the reporting periods [8] - The company has a high inventory risk, with inventory values of 314 million yuan, 393 million yuan, 418 million yuan, and 436 million yuan at the end of each reporting period, representing a significant portion of current assets [9]
IPO雷达|万润股份子公司九目化学获受理,营收依赖外销关税利剑高悬,主力产品售价滑坡